Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

Inclusion Criteria: * Patient with newly diagnosed brain metastases * Patient with cancer regardless of the type of primary cancer, with anatomopathological proof * At least, one measurable lesion ≥ 10 mm on the MRI T1 gadolinium sequences * Number of brain metastases lower or equal to 5 * Indication of radiosurgery treatment * Age ≥ 18 years old * ECOG-PS 0-2 * Expected survival \> 3 months * Ability to complete self-administered questionnaires. If the patient has a motor disability (hemibody deficit) that does not allow to complete himself the questionnaires, these will be read by a CRA of the Neurosurgery department who will outline the questions without making any comment. * A non-opposition form must have been completed by the patient Exclusion Criteria: * Previous cancer (\< 5 years) except of carcinoma of cervix uteri, basal cell or squamous cell skin carcinoma adequately treated * Previous brain radiotherapy * Neurological pathology with cognitive disorders existing before the study * Having a contraindication for MRI * Associated leptomeningeal disease * Patients having another severe or uncontrolled pathology which could compromise the participation at the study (such as infection, cardiovascular, digestive, renal or pulmonary disease) * Pregnant or breastfeeding woman. The women must not breastfeed for at least 6 months * Impossibility to submit to the medical examinations of the study due to geographic, social or mental reasons